Unknown

Dataset Information

0

Computational analysis of ligand-receptor interactions in wild-type and mutant erythropoietin complexes.


ABSTRACT: Background:Erythropoietin (EPO), a pleiotropic cytokine, binds to its receptor (EPOR) in bone marrow, activating a signaling cascade that results in red blood cell proliferation. A recently discovered naturally occurring EPO mutation (R150Q) at active site 1 (AS1) of the protein was shown to attenuate its canonical downstream signaling, eliminating its hematopoietic effects and causing a fatal anemia. The purpose of this work was to analyze the EPO-EPOR complex computationally to provide a structural explanation for this signaling change. Materials and methods:Computational structural biology analyses and molecular dynamics simulations were used to determine key interaction differences between the R150Q mutant and the wild-type form of EPO. Both were compared to another variant mutated at the same position, R150E, which also lacks hematopoietic activity. Results:The ligand-receptor interactions of the R150Q and R150E mutants showed significant variations in how they interacted with EPOR at AS1 of the EPO-EPOR complex. Both lost specific reported salt bridges previously associated with full complex activation. Conclusion:This work describes how the ligand-receptor interactions at AS1 of the EPO- EPOR complex respond to mutations at the 150th position. The interactions at AS1 were used to propose a potential mechanism by which the binding of EPO to the extracellular domain of EPOR influences its cytosolic domain and the resulting signaling cascade.

SUBMITTER: Pekas NJ 

PROVIDER: S-EPMC6197206 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Computational analysis of ligand-receptor interactions in wild-type and mutant erythropoietin complexes.

Pekas Nicholas J NJ   Newton Samuel S SS  

Advances and applications in bioinformatics and chemistry : AABC 20181015


<h4>Background</h4>Erythropoietin (EPO), a pleiotropic cytokine, binds to its receptor (EPOR) in bone marrow, activating a signaling cascade that results in red blood cell proliferation. A recently discovered naturally occurring EPO mutation (R150Q) at active site 1 (AS1) of the protein was shown to attenuate its canonical downstream signaling, eliminating its hematopoietic effects and causing a fatal anemia. The purpose of this work was to analyze the EPO-EPOR complex computationally to provide  ...[more]

Similar Datasets

| S-EPMC2850907 | biostudies-literature
| S-EPMC1303478 | biostudies-literature
| S-EPMC3877123 | biostudies-literature
| S-EPMC6479630 | biostudies-literature
| S-EPMC11311534 | biostudies-literature
| S-EPMC8513022 | biostudies-literature
| S-EPMC8809538 | biostudies-literature
| S-EPMC5483895 | biostudies-literature
| S-EPMC6282305 | biostudies-literature
| S-EPMC3222595 | biostudies-literature